A Survey of Medical Residents’ Knowledge, Attitude, and Practice about Drug–Drug Interactions, Shiraz, Iran

References

• Abdo, M. S., M. A. Hammad, S. N. Harun, T. M. Eusoff, and S. M. Sheikh Ghadzi. 2020. Evaluation of knowledge, attitude and practice of healthcare providers towards life-threatening drug-drug interactions in Penang General Hospital, Malaysia. Clin. Epidemiol. Glob. Health 8 (4):1253–8. doi: 10.1016/j.cegh.2020.04.023.
   Web of Science ®Google Scholar
• Andersson, M. L., Y. Böttiger, J. D. Lindh, B. Wettermark, and B. Eiermann. 2013. Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care. Eur. J. Clin. Pharmacol. 69 (3):565–71. doi: 10.1007/s00228-012-1338-y.
   PubMed Web of Science ®Google Scholar
• Bucşa, C., A. Farcaş, I. Cazacu, D. Leucuta, A. Achimas-Cadariu, C. Mogosan, and M. Bojita. 2013. How many potential drug-drug interactions cause adverse drug reactions in hospitalized patients? Eur. J. Internal Med. 24 (1):27–33. doi: 10.1016/j.ejim.2012.09.011.
   PubMed Web of Science ®Google Scholar
• Chumney, E. C, and L. C. Robinson. 2006. The effects of pharmacist interventions on patients with polypharmacy. Pharm. Pract. 4 (3):103–9.
   PubMedGoogle Scholar
• Glassman, P. A., B. Simon, P. Belperio, and A. Lanto. 2002. Improving recognition of drug interactions: benefits and barriers to using automated drug alerts. Med. Care 40 (12):1161–71. doi: 10.1097/00005650-200212000-00004.
   PubMed Web of Science ®Google Scholar
• Haji Aghajani, M., M. Sistanizad, M. Abbasinazari, M. Abiar Ghamsari, L. Ayazkhoo, O. Safi, K. Kazemi, and M. Kouchek. 2013. Potential drug-drug interactions in post-CCU of a teaching hospital. Iran. J. Pharm. Res. 12 (1):243–8.
   PubMed Web of Science ®Google Scholar
• Hammes, J. A., F. Pfuetzenreiter, F. Silveira, A. Koenig, and G. A. Westphal. 2008. Potential drug interactions prevalence in intensive care units. Revista Brasileira de Terapia Intensiva 20 (4):349–54.
   PubMedGoogle Scholar
• Harrington, A. R., T. L. Warholak, L. E. Hines, A. M. Taylor, D. Sherrill, and D. C. Malone. 2011. Healthcare professional students’ knowledge of drug-drug interactions. Am. J. Pharm. Educ. 75 (10):199.
   PubMed Web of Science ®Google Scholar
• Janchawee, B., W. Wongpoowarak, T. Owatranporn, and V. Chongsuvivatwong. 2005. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J. Clin. Pharm. Ther. 30 (1):13–20. doi: 10.1111/j.1365-2710.2004.00598.x.
   PubMed Web of Science ®Google Scholar
• Juurlink, D. N., M. Mamdani, A. Kopp, A. Laupacis, and D. A. Redelmeier. 2003. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289 (13):1652–8. doi: 10.1001/jama.289.13.1652.
   PubMed Web of Science ®Google Scholar
• Ko, Y., D. C. Malone, G. H. Skrepnek, E. P. Armstrong, J. E. Murphy, J. Abarca, R. A. Rehfeld, S. J. Reel, and R. L. Woosley. 2008. Prescribers’ knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug Saf. 31 (6):525–36. doi: 10.2165/00002018-200831060-00007.
   PubMed Web of Science ®Google Scholar
• Ko, Y., D. C. Malone, G. H. Skrepnek, E. P. Armstrong, J. E. Murphy, J. Abarca, R. A. Rehfeld, S. J. Reel, and R. L. Woosley. 2008. Prescribers’ knowledge of and sources of information for potential drug-drug interactions. Drug Saf. 31 (6):525–36. doi: 10.2165/00002018-200831060-00007.
   PubMed Web of Science ®Google Scholar
• Ko, Y., J. Abarca, D. C. Malone, D. C. Dare, D. Geraets, A. Houranieh, W. N. Jones, W. P. Nichol, G. P. Schepers, M. Wilhardt, et al. 2007. Practitioners’ views on computerized drug-drug interaction alerts in the VA system. J. Am. Med. Inform. Assoc. 14 (1):56–64. doi: 10.1197/jamia.M2224.
   PubMed Web of Science ®Google Scholar
• Launiala, A. 2009. How much can a KAP survey tell us about people's knowledge, attitudes and practices? Some observations from medical anthropology research on malaria in pregnancy in Malawi. Anthropol. Matters 11 (1):1–13. doi: 10.22582/am.v11i1.31.
   Google Scholar
• Nabovati, E., H. Vakili-Arki, Z. Taherzadeh, M. R. Saberi, A. Abu-Hanna, and S. Eslami. 2017. A survey of attitudes, practices, and knowledge regarding drug-drug interactions among medical residents in Iran. Int. J. Clin. Pharm. 39 (3):560–8. doi: 10.1007/s11096-017-0453-3.
   PubMed Web of Science ®Google Scholar
• Noormandi, A., I. Karimzadeh, M. Mirjalili, and H. Khalili. 2019. Clinical and economic impacts of clinical pharmacists’ interventions in Iran: a systematic review. Daru 27 (1):361–78. doi: 10.1007/s40199-019-00245-8.
   PubMed Web of Science ®Google Scholar
• Onco-Informatics (onco-informatics. com) Group. 2010. Opinions on drug interaction sources in anticancer treatments and parameters for an oncology-specific database by pharmacy practitioners in Asia. Health Serv. Insights 3:1–12.
   Google Scholar
• Ranjith, Y., P. Jagadish, M. D. Janodia, S. Vasantharaju, G. G. Shenoy, and N. Udupa. 2012. An overview of non-prescription drug regulations for India, United States, Australia and Europe. Inventi Rapid: Pharm. Pract. 2012 (1):1–6.
   Google Scholar
• Rodrigues, A. T., R. Stahlschmidt, S. Granja, A. L. Falcão, P. Moriel, and P. G. Mazzola. 2015. Clinical relevancy and risks of potential drug-drug interactions in intensive therapy. Saudi Pharm. J. 23 (4):366–70. doi: 10.1016/j.jsps.2014.11.014.
   PubMed Web of Science ®Google Scholar
• Sharma, A., K. Sharma, K. Neemawat, L. Sharma, and D. Pilania. 2019. Concurrent prescribing: Evaluation of its knowledge among dentists. Natl. J. Maxillofac. Surg. 10 (1):73–7. doi: 10.4103/njms.NJMS_21_18.
   PubMedGoogle Scholar
• Srinivasan, R., and G. Ramya. 2011. Adverse drug reaction-causality assessment. Int. J. Res. Pharm. Chem. 1 (3):606–12.
   Google Scholar
• Strom, B. L., R. Schinnar, W. Bilker, S. Hennessy, C. E. Leonard, and E. Pifer. 2010. Randomized clinical trial of a customized electronic alert requiring an affirmative response compared to a control group receiving a commercial passive CPOE alert: NSAID–warfarin co-prescribing as a test case. J. Am. Med. Inform. Assoc. 17 (4):411–5. doi: 10.1136/jamia.2009.000695.
   PubMed Web of Science ®Google Scholar
• Yimer, M., B. Abera, W. Mulu, and B. Bezabih. 2014. Knowledge, attitude and practices of high risk populations on louse-borne relapsing fever in Bahir Dar city, north-west Ethiopia. Sci. J. Public Health 2 (1):15–22. doi: 10.11648/j.sjph.20140201.13.
   Google Scholar